NVIDIA BioNeMo has introduced a new context parallelism framework designed to overcome memory limitations in biomolecular modeling, enabling the holistic simulation of massive protein complexes that were previously impossible to fold. Traditionally, computational biology relied on reductionist strategies, slicing large proteins into smaller fragments to fit within the memory of single GPUs. This approach often sacrificed global structural accuracy, preventing researchers from capturing long-range interactions such as allosteric effects or signal transduction across entire complexes. The new framework addresses these constraints by sharding a single large molecular system across multiple GPUs. Unlike standard data parallelism, which assigns different proteins to different devices, context parallelism splits one massive sample across the network. Built on Torch distributed APIs, the architecture employs a bottom-up approach, starting with low-level communication protocols and scaling up to model-specific workflows. This implementation utilizes a multidimensional sharding strategy to ensure linear capacity scaling, meaning the system's capability grows proportionally with the number of GPUs without any single device holding the full global state. Key technical innovations include the 2D tiling of pair representation matrices, which partitions large interaction grids into sub-blocks managed by individual GPUs. This reduces the memory footprint per device from quadratic complexity to a manageable fraction. The system also overlaps computation with communication by orchestrating asynchronous peer-to-peer transfers while GPUs perform local updates. Additionally, the framework adapts local attention mechanisms for atom sequences using halo-exchange primitives to eliminate unnecessary inter-GPU communication during specific attention windows. These optimizations allow the model to process inputs as distributed tensors, ensuring that massive activation tensors remain within the memory limits of individual hardware units. The impact of this technology is significant for structural biology. Using the Boltz architecture, researchers successfully folded a complex TTC7A/PI4KA/FAM126A/EFR3A system containing 3,605 residues across four chains. This system far exceeds the typical training crop size of 768 residues and the capacity of a single GPU. The prediction generated five structural samples in under five minutes using four NVIDIA H100 GPUs while maintaining all long-range inter-subunit contacts. Scaling tests indicate that the framework can support up to 20,000 tokens using 256 GPUs, with further acceleration expected on upcoming NVIDIA B300 hardware. Collaborators have already integrated this framework to accelerate drug discovery. Rezo Therapeutics used the technology to predict protein-protein interactions spanning up to 6,500 residues, achieving a three-fold enrichment in high-quality novel complex predictions compared to traditional methods. Proxima embedded the framework into its Neo foundation model to resolve therapeutically relevant interactions up to 4,000 tokens, aiding in the development of molecular glues. Similarly, Earendil Labs applied the method to extend input sequence lengths for their proprietary models, demonstrating the potential to maintain high-fidelity predictions as sequence complexity increases. Despite these breakthroughs, physical memory capacity alone does not guarantee biological accuracy. Current models trained on small fragments may struggle with emergent long-range interactions. To address this, the research team is leveraging NVIDIA accelerated computing software to generate synthetic data for massive complexes, which will be added to the AlphaFold Protein Structure Database. This effort aims to provide the large-scale training data necessary to fine-tune foundation models for accurate, full-system biological modeling. The underlying code for this context parallelism framework is available through open-source documentation.